Patient stratification for determining optimal second and third line therapy for type 2 diabetes: the TriMaster study

Precision medicine aims to treat an individual based on their clinical characteristics. A differential drug response, critical to using these features for therapy selection, has never been examined directly in type 2 diabetes. We tested two hypotheses: 1) individuals with BMI>30kg/m(2), compared...

Descripción completa

Detalles Bibliográficos
Autores principales: Shields, Beverley M, Dennis, John M, Angwin, Catherine D, Warren, Fiona, Henley, William E, Farmer, Andrew J, Sattar, Naveed, Holman, Rury R, Jones, Angus G, Pearson, Ewan R, Hattersley, Andrew T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7614216/
https://www.ncbi.nlm.nih.gov/pubmed/36477733
http://dx.doi.org/10.1038/s41591-022-02120-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7614216/
https://www.ncbi.nlm.nih.gov/pubmed/36477733
http://dx.doi.org/10.1038/s41591-022-02120-7

Ejemplares similares